徐國辰，男，博士，心血管專業(yè)，副主任醫(yī)師。 1983~1989第四軍醫(yī)大學(xué)醫(yī)療系本科，獲學(xué)士學(xué)位；1991~1994第四軍醫(yī)大學(xué)研究生院心血管病學(xué)專業(yè)，獲碩士學(xué)位；2003~2005第四軍醫(yī)大學(xué)藥學(xué)系藥理學(xué)專業(yè)/北京大學(xué)人民醫(yī)院心血管病研究所，獲博士學(xué)位。 師從張寧仔、杜日映教授攻讀碩士學(xué)位期間，從事全軍“八五”攻關(guān)課題“血管支架預(yù)防/治療PTA/PTCA術(shù)后急性閉塞與慢性再狹窄”研究，研制成功首例國產(chǎn)不銹鋼動(dòng)脈血管支架。 師從梅其柄、胡大一教授攻讀博士學(xué)位期間，從事“藥物基因組學(xué)與脂代謝紊亂患者的個(gè)體化治療”研究，開始涉足藥物相互作用和藥物個(gè)體化治療與遺傳基因多態(tài)性的相關(guān)研究領(lǐng)域。 自2000年從事心血管?？崎T診工作以來，開展心血管疾病的循證醫(yī)學(xué)研究，發(fā)表相關(guān)研究論文20余篇，參編心血管病學(xué)專著2部。2000年獲國家衛(wèi)生部、中國中醫(yī)藥管理局、解放軍總后勤部聯(lián)合舉辦的“中國中醫(yī)藥科技大會(huì)”優(yōu)秀論文獎(jiǎng)；2004年赴新加坡參加“亞洲青年心血管病專家論壇”國際會(huì)議，就在中國本土開展的“藥物基因組學(xué)與脂代謝紊亂患者的個(gè)體化治療研究”發(fā)表演講。 Dr. Xu Guochen, associate chief physician, specializes in cardiovascular diseases. Dr. Xu graduated from the department of medicine (six-year course) of the Fourth Military Medical University in 1989, and was awarded Medical Bachelor Degree. He majored cardiovascular diseases at graduate school of the Fourth Military Medical University from 1991 to 1994, and was awarded Master Degree of Medical Science. He majored in cardiovascular pharmacology at the department of pharmacology of the Fourth Military Medical University and Angiocardiopathy Institute of Peking University People's Hospital from 2002 to 2005, and was awarded Doctoral Degree of Medical Science. Dr. Xu studied for master degree under supervision of professors Zhang Ningzi and Du Riying, and his research was focused on Preventing/Curing PTA/PTCA Postoperative Acute Closure and Chronic Restenosis by using Stent for Key Technologies Research and Development Program of the army during the 8th Five-Year Plan Period. He successfully developed the first domestic stainless steel coronary stent in China. Dr. Xu’s doctoral study on pharmacogenomics of individualized treatment of lipid metabolism disorder was conducted under supervision of professors Mei Qibing and Hu Dayi. Meanwhile Dr. Xu initiated the investigation on drug interactions, clinical individualized treatment genetic polymorphism. Dr. Xu has been working on evidence-based cardiovascular medicine since 2000. He has published more than 20 research articles, and participated in compil

高血壓 冠心病 心律失常等心血管病的診斷與藥物治療；冠狀動(dòng)脈造影 血管內(nèi)支架植入 射頻消融術(shù)等介入診療的前瞻指導(dǎo)與術(shù)后維護(hù)。在臨床實(shí)踐中從哲學(xué)層面把握藥物、心理、行為指導(dǎo)的個(gè)體化治療；在基礎(chǔ)研究方面主要從事基因多態(tài)性 藥物基因組學(xué)與循證心血管病學(xué)領(lǐng)域的研究